No Data
No Data
Korro Bio Appoints Interim CFO Amid Medical Leave
Express News | Korro Bio Inc - CEO Ram Aiyar Appointed Interim Principal Financial Officer
Express News | Korro Bio Inc - CFO Vineet Agarwal Takes Temporary Medical Leave
Korro Bio's RNA Editing Potential: A Buy Rating With Promising Catalysts and Commercial Opportunities
Piper Sandler Maintains Korro Bio(KRRO.US) With Buy Rating, Maintains Target Price $180
Express News | Korro Bio Announces Dosing of First Participants in Rewrite Phase 1/2a Study of Krro-110 for Alpha-1 Antitrypsin Deficiency and Provides Pipeline Update
Stock Therapy : what app/screener is this?